Three things to know:
1. The device is designed to treat inner knee osteoarthritis symptom without alternating the anatomy or removing tissue or bone from the knee. The implant is intended to absorb excess knee loads that can cause pain in patients with osteoarthritic joints.
2. Researchers will study approximately 80 patients who receive the implant. Wexner Medical Center is one of four trial sites.
3. “This device works like a shock absorber to take pressure off the inside of the knee while creating a cushion similar to what cartilage provides in a healthy joint,” Dr. Flanigan told The Intelligencer and Wheeling News Register. “The hope is that it increases joint functionality, reduces pain and delays a total knee arthroplasty for years or even decades.”
More articles on devices:
Medtronic Q3 spine revenue flat at $655M, Mazor X & StealthStation help drive neurosurgery growth: 6 things to know
Customized knee implants cost less than standard implants — 5 study insights
Integra LifeSciences launches nail system for ankle fusion: 3 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
